These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 34888629)

  • 1. Somatic mutations in rheumatological diseases: VEXAS syndrome and beyond.
    Sikora KA; Wells KV; Bolek EC; Jones AI; Grayson PC
    Rheumatology (Oxford); 2022 Aug; 61(8):3149-3160. PubMed ID: 34888629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic mutations in VEXAS Syndrome and Erdheim-Chester disease: Inflammatory myeloid diseases.
    Alcedo PE; Gutierrez-Rodrigues F; Patel BA
    Semin Hematol; 2022 Jul; 59(3):156-166. PubMed ID: 36115693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases.
    Vitale A; Caggiano V; Bimonte A; Caroni F; Tosi GM; Fabbiani A; Renieri A; Bocchia M; Frediani B; Fabiani C; Cantarini L
    Intern Emerg Med; 2023 Apr; 18(3):711-722. PubMed ID: 36662445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Looking beyond VEXAS: Coexistence of undifferentiated systemic autoinflammatory disease and myelodysplastic syndrome.
    Oganesyan A; Hakobyan Y; Terrier B; Georgin-Lavialle S; Mekinian A
    Semin Hematol; 2021 Oct; 58(4):247-253. PubMed ID: 34802547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS.
    Ferrada MA; Sikora KA; Luo Y; Wells KV; Patel B; Groarke EM; Ospina Cardona D; Rominger E; Hoffmann P; Le MT; Deng Z; Quinn KA; Rose E; Tsai WL; Wigerblad G; Goodspeed W; Jones A; Wilson L; Schnappauf O; Laird RS; Kim J; Allen C; Sirajuddin A; Chen M; Gadina M; Calvo KR; Kaplan MJ; Colbert RA; Aksentijevich I; Young NS; Savic S; Kastner DL; Ombrello AK; Beck DB; Grayson PC
    Arthritis Rheumatol; 2021 Oct; 73(10):1886-1895. PubMed ID: 33779074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder.
    Huang H; Zhang W; Cai W; Liu J; Wang H; Qin T; Xu Z; Li B; Qu S; Pan L; Huang G; Gale RP; Xiao Z
    Exp Hematol Oncol; 2021 Mar; 10(1):23. PubMed ID: 33741056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on VEXAS syndrome.
    Al-Hakim A; Savic S
    Expert Rev Clin Immunol; 2023 Feb; 19(2):203-215. PubMed ID: 36537591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal Hematopoiesis, Inflammation, and Hematologic Malignancy.
    Kanagal-Shamanna R; Beck DB; Calvo KR
    Annu Rev Pathol; 2024 Jan; 19():479-506. PubMed ID: 37832948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary manifestations in VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome: a systematic review.
    Kouranloo K; Ashley A; Zhao SS; Dey M
    Rheumatol Int; 2023 Jun; 43(6):1023-1032. PubMed ID: 36617363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Macrocytic anemia and polychondritis: VEXAS syndrome].
    Zeisbrich M; Schindler V; Krausz M; Proietti M; Mrovecova P; Voll RE; Glaser C; Röther F; Warnatz K; Venhoff N
    Z Rheumatol; 2024 Apr; 83(3):229-233. PubMed ID: 36735069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Manifestations in Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome: A Narrative Review.
    Padureanu V; Marinaș CM; Bobirca A; Padureanu R; Patrascu S; Dascalu AM; Bobirca F; Tribus L; Alexandru C; Serboiu C; Dumitrascu C; Musetescu A
    Cureus; 2024 Jan; 16(1):e53041. PubMed ID: 38410307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEXAS syndrome: a diagnostic puzzle.
    Ruffer N; Krusche M
    RMD Open; 2023 Aug; 9(3):. PubMed ID: 37532466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEXAS-Syndrome, a newly described autoinflammatory systemic disease with dermatologic manifestations.
    Baur V; Stoevesandt J; Hueber A; Hüffmeier U; Kneitz H; Morbach H; Schultz E; Goebeler M
    J Dtsch Dermatol Ges; 2023 Dec; 21(12):1456-1463. PubMed ID: 37953404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UBA1 and DNMT3A mutations in VEXAS syndrome. A case report and literature review.
    Shaukat F; Hart M; Burns T; Bansal P
    Mod Rheumatol Case Rep; 2022 Jan; 6(1):134-139. PubMed ID: 34480172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azacitidine for patients with Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry.
    Comont T; Heiblig M; Rivière E; Terriou L; Rossignol J; Bouscary D; Rieu V; Le Guenno G; Mathian A; Aouba A; Vinit J; Dion J; Kosmider O; Terrier B; Georgin-Lavialle S; Fenaux P; Mekinian A;
    Br J Haematol; 2022 Feb; 196(4):969-974. PubMed ID: 34651299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS syndrome) with prominent supraglottic larynx involvement: a case-based review.
    Guerrero-Bermúdez CA; Cardona-Cardona AF; Ariza-Parra EJ; Arostegui JI; Mensa-Vilaro A; Yague J; Vásquez G; Muñoz-Vahos CH
    Clin Rheumatol; 2022 Nov; 41(11):3565-3572. PubMed ID: 35986821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleuropulmonary Manifestations of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome.
    Borie R; Debray MP; Guedon AF; Mekinian A; Terriou L; Lacombe V; Lazaro E; Meyer A; Mathian A; Ardois S; Vial G; Moulinet T; Terrier B; Jamilloux Y; Heiblig M; Bouaziz JD; Zakine E; Outh R; Groslerons S; Bigot A; Flamarion E; Kostine M; Henneton P; Humbert S; Constantin A; Samson M; Bertrand NM; Biscay P; Dieval C; Lobbes H; Jeannel J; Servettaz A; Adelaide L; Graveleau J; de Sainte-Marie B; Galland J; Guillotin V; Duroyon E; Templé M; Bourguiba R; Georgin Lavialle S; Kosmider O; Audemard-Verger A;
    Chest; 2023 Mar; 163(3):575-585. PubMed ID: 36272567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic manifestations of VEXAS syndrome.
    Groarke EM; Dulau-Florea AE; Kanthi Y
    Semin Hematol; 2021 Oct; 58(4):230-238. PubMed ID: 34802545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEXAS within the spectrum of rheumatologic disease.
    Koster MJ; Warrington KJ
    Semin Hematol; 2021 Oct; 58(4):218-225. PubMed ID: 34802543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with VEXAS diagnosed in a Danish tertiary rheumatology setting have highly elevated inflammatory markers, macrocytic anaemia and negative autoimmune biomarkers.
    Rasch MNB; Szabados F; Jensen JMB; Nielsen KO; Hauge EM; Troldborg A
    RMD Open; 2022 Sep; 8(2):. PubMed ID: 38967099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.